Enhancing Intradermal Delivery of Lidocaine by Dissolving Microneedles: Comparison between Hyaluronic Acid and Poly(Vinyl Pyrrolidone) Backbone Polymers

Lidocaine hydrochloride (LiH), an amide-type local anesthetic agent, is commonly used in dermatological procedures. LiH is categorized as a BCS (biopharmaceutics classification system) class III group, which has high solubility and poor permeability. It should be noted that, in this context, LiH is intended as a local anesthetic, so the level of LiH in systemic circulation should be minimized to avoid toxicity and unwanted side effects such as hypotension and bradycardia. This study aimed to formulate and evaluate LiH-loaded dissolving microneedles (DMNs) with different polymer bases.

Moreover, an in vitro permeation study using Franz diffusion cells and in vivo study were also performed. LiH-loaded DMNs were prepared using polymer groups of poly(vinyl pyrrolidone) (PVP-K30) and hyaluronic acid (HA). DMNs were created using the micro-molding method with centrifugation. The formulations selected based on the evaluation were F3 (HA 10%) and F5 (PVP-K30 25%). Based on the in vitro permeation study, the amount of drug permeated and deposited in the skin at F3 (HA 10%) was 247.1 ± 41.85 and 98.35 ± 12.86 μg, respectively. On the other hand, the amount of drug permeated and deposited in the skin at F5 (PVP-K30 25%) was 277.7 ± 55.88 and 59.46 ± 9.25 μg, respectively.

Our in vivo drug-permeation study showed that only one rat from the PVP-K30 polymer group—with a concentration of 150.32 ng/mL—was detected on rat plasma. Therefore, LiH can be formulated into a DMN and can be deposited in the skin with a safe concentration of the drug permeating into systemic circulation.

Download the full article as PDF here Enhancing Intradermal Delivery of Lidocaine by Dissolving Microneedles_Comparison between Hyaluronic Acid and PolyVinyl Pyrrolidone Backbone Polymers

read more

Materials

Lidocaine hydrochloride (LiH) was given by PT Phapros, Indonesia. Hyaluronic acid (HA) (Mw ~60 kDa) was purchased from Shandong Topscience Biotech Co., Ltd., Rizhao, China. Polyvinyl pyrrolidone K30 (PVP-K30) (30–40 kDa) was purchased from BASF, Hong Kong. All chemical and reagents used in this study were analytical grade. All solvents used for analytical study were HPLC-grade.

Ramadon, D.; Sutrisna, L.F.P.; Harahap, Y.; Putri, K.S.S.; Ulayya, F.; Hartrianti, P.; Anjani, Q.K.; Donnelly, R.F. Enhancing Intradermal Delivery of Lidocaine by Dissolving Microneedles: Comparison between Hyaluronic Acid and Poly(Vinyl Pyrrolidone) Backbone Polymers. Pharmaceutics 2023, 15, 289., https://doi.org/10.3390/pharmaceutics15010289

Remember the World Cancer Day 4^th February 2023. For more information click on the picture below: